A THERAPY AGAINST LEUKEMIA AT CHILDREN AND NOT ONLY, DEVELOPED IN USA

In the USA the drug-authority FDA has approved a therapy when at a patient blood cells genetically will be altered by filtering of T cells from the blood of the patient. They will be given to the patient, can multiply in the body and can counteract against the disease. The therapy especially against Leukemia at children was developed by Novartis in the university of Pennsylvania.

ARTICOLE SIMILARE